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1  Non-Genetic Inheritance
It is well understood that heritable traits which influence 
phenotype are transmitted from parents to offspring via 
DNA (Mendelian genetics/genetic inheritance) and that, 
aside from exposure to environmental factors such as 
mutagens which can target DNA in a non-random manner 
(i.e. histone bound DNA in sperm is more prone to DNA 
damage than the tightly package DNA bound by protamines 
[1]), sequence changes are primarily random [2]. Studies 
have linked DNA mutations in single/small groups of genes 
to specific phenotypic changes in the offspring; however 
it is becoming increasingly evident that environmental 
factors can also influence offspring phenotype and 
although genome wide association studies have 
identified weak associations between single nucleotide 
polymorphisms (SNP’s) and altered phenotype including 
risk of disease onset later in life, epigenetic programming 
is likely the primary determinant of environment based 
phenotypic programming [3]. Non-genetic inheritance 
or ‘epigenetics’ describes the transmittable change in 
the function of the genetic material without altering the 
DNA sequence. These changes can occur at the DNA level 
(i.e. methylation of CpG dinucleotides), chromatin level 
(i.e. acetylation/deacetylation of histones) and at the 
translation regulation level (i.e. microRNAs and other 
small non-coding RNAs) with these epigenetic processes 
able to be regulated by environmental factors [4]. 
2  Parental environmental 
exposures influence offspring 
health 
There is accumulating evidence that the environment the 
developing fetus (and thus the developing germ line) is 
exposed to can significantly influence phenotype and 
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susceptibility to disease later in life and that these changes 
can persist across multiple generations. One early example 
of this is demonstrated through the use of diethylstilbestrol 
(DES), a non-steroidal estrogen which was prescribed to 
women during pregnancy in the 1970’s to decrease the risk 
of miscarriage [5]. The use of DES during the first trimester 
increased the risk of cancer in female offspring and this 
increased risk was also seen in the subsequent generation 
[6] as well as inducing reproductive tract dysfunction 
and poor pregnancy outcomes [7, 8]. It is believed that 
these abnormalities are due to altered DNA methylation 
of a homeobox gene (HOXA10) which was passed directly 
through the germline providing evidence of non-genetic 
inheritance of disease [9]. 
Further evidence from the Dutch winter famine 
demonstrated that babies, born to women suffering poor 
nutrition due to food embargos during World War II, were 
significantly smaller at birth and that this was repeated 
in the subsequent generation despite no further dietary 
restrictions [10]. This decreased birth weight was linked 
to obesity, increased risk for coronary heart disease and 
impaired glucose tolerance later in life [11]. In addition 
it has also been shown that paternal grandparent’s 
food supply is also linked to the mortality rate in the 
grandchildren in a sex specific manner [12]. Interesting, 
while parental under-nutrition significantly altered their 
children’s risk for chronic disease, it did not appear to 
impact their fertility, with subsequent females having 
increased numbers of children born compared with 
females born from mothers who were normally fed [13, 
14]. In direct contrast, parental over nutrition does appear 
to play a role in programming offspring fertility, with 
maternal overweight/obesity during pregnancy increasing 
premature onset of puberty in daughters [15] and reducing 
sperm concentration, semen volume, sperm motility and 
testosterone levels in sons [16, 17]. This is also supported by 
studies in animal models that show that paternal obesity 
at conception perturbs sperm function of male offspring 
(decreased sperm motility and increased sperm reactive 
oxygen species and DNA damage) and alters oocyte 
quality in female offspring (reduced meiotic progression 
and altered mitochondrial membrane potential) [18]. 
In addition to nutrition, other parental environmental 
perturbations prior to or during pregnancy have been 
linked to infertility in offspring. Maternal smoking 
during gestation decreases testes weights and the 
number of developing germ cells in male fetuses [19] 
leading to an overall reduction in adult sperm counts 
and fertility [20]. Intrauterine growth restriction (IUGR) 
is also linked to fertility issues in both male and female 
offspring by reducing ovarian and testes size, inducing 
cryptorchidism, reducing numbers of primordial follicles, 
increasing FSH levels, decreasing uterine volume and 
reducing sperm counts and testosterone levels after 
puberty [21-25]. However whether all of these changes 
are due to direct effects (including genetic effects) as a 
consequence of in utero exposure cannot be ruled out at 
this stage. While human studies have not demonstrated a 
mechanism for these changes to offspring fertility, studies 
on in utero exposures of male offspring to different 
environmental toxins which results in perturbed fertility 
of the males also results in alteration to the epigenetic 
signature of the sperm with changes to methylation marks 
in spermatogonia detected in the F3 generation giving 
support to the fact that this may be non-genetic in origin 
[26, 27].
3  Environment Impairing Epigene-
tic Signatures Of Gametes
The developing gamete is highly sensitive to the 
surrounding environment with both maternal and 
paternal health/diet and exposure to toxins having a 
significant effect on, not only gamete viability, but also 
on the epigenetic fingerprint of the gametes. While little 
is known about the specific effects of smoking on the 
epigenetic composition of the oocyte, there are several 
studies that have linked smoking to inducing aberrant 
changes to epigenetic marks in sperm [12, 28-30]. One 
study determined that the microRNA content of sperm was 
altered in smokers and interestingly these microRNAs were 
associated with pathways important for the development 
of the embryo [28] and it has been demonstrated that 
smoking increases the oxidative stress in sperm, which 
increases DNA damage and oxidative adducts that may 
contribute to altered transcriptome and the observed 
poorer embryo development [31]. Epigenetic programming 
also plays a critical role in male fertility with aberrant 
epigenetic regulation/modifications being linked to a wide 
variety of sperm morphological defects [32, 33]. There are 
now several studies that have related oligiospermia and 
azospermia to perturbed DNA methylation including both 
hypomethylation and hypermethylation [34]. In addition, 
male infertility is linked to alterations in the abundance 
and composition of non-coding RNA content of sperm with 
infertility as well as retention of histones [35] however the 
environmental cause of this is currently unknown. 
Further, small non-coding RNAs represent a group 
of RNAs that are 18-24 bases long and include repetitive 
elements, transcription start sites, (piRNAs, miRNAs, 
snRNAs, snoRNAs, mse-tsRNA and YRNAs) which are 
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important for controlling epigenetic reprogramming of 
the male and female pronucleus [36-39]. Both oocyte 
and sperm specific small non coding RNAs have been 
proposed to aid in the degradation of maternal mRNA [36], 
provide signals for early embryonic histone replacement 
in the male pronucleus [40], transcriptionally poise the 
genome for early embryonic expression [41], and are vital 
for first cleavage division [42] and regulation of epigenetic 
state [43]. Both maternal and paternal environmental 
factors (i.e. smoking and diet/weight) have been shown 
to influence small non coding RNAs [44, 45], implicating 
them as potential mediators in the developmental origins 
of adult disease.  
4  Non-Genetic Inheritance and IVF 
Technology- is there a Link?
Although it has been demonstrated that some children 
born from assisted reproductive technology (ART) have 
a different phenotype compared to children born from 
natural conception, the definitive link between ART and 
non-genetic inheritance has yet to be made although the 
early emerging evidence is cause for concern.
The demonstration that epigenetic marks of gametes 
and early preimplantation embryos are susceptible 
to environmental insults is of interest for assisted 
reproductive technologies where the gametes and early 
embryos are manipulated in vitro. A number of recent 
studies have now shown that children born as a result 
of ART have an increased risk of being born preterm, are 
at increased risk of neonatal death, display higher rates 
of birth defects and increased rates of genetic disorders 
[46, 47]. Whether such changes are genetic or non-genetic 
in origin is currently unclear as sub-fertile couples who 
conceive naturally display similar risks of pregnancy 
complications and neonatal risks as those conceived by 
ART [46, 47], with the contribution of the technology itself 
in programming offspring phenotype also the subject of 
some contention. Considerable advances have been made 
in IVF technology since the birth of the first IVF child, Louise 
Brown, in 1978. Changes to the culture environment and 
media, drugs used for ovarian stimulation, insemination 
technique and cryopreservation have led to the significant 
improvement in IVF outcomes as measured by pregnancy 
rates with an increase in singleton births. However, 
despite these considerable advances, the technology has 
been suggested to increase risk of altering non-genetic 
inheritance and programming [48-50].
4.1  Ovarian Hyperstimulation
One of the most common components of an IVF cycle 
is the use of hormones to stimulate the development of 
multiple follicles designed to improve the success rates 
of IVF by providing more oocytes to begin the process. 
It is well understood that this time of follicle and oocyte 
growth involves significant epigenetic remodelling in the 
developing and maturing oocyte which are sensitive to 
environmental exposures [51-53]. Data from animal models 
supports the notion that ‘over-riding’ of the natural 
hormonal cycle is in itself associated with molecular 
changes to the oocyte which may impact on development 
of the embryo and pregnancy. A mouse study established 
that the superovulation process altered the epigenetic 
marks in oocytes with disrupted H19 expression and loss 
of methylation in several maternally imprinted genes 
in a dose-dependent manner [54]. Further, studies on 
both mice and cows have demonstrated changes to the 
epigenetic marks in the oocytes as well as fundamental 
changes in the epigenetic machinery of the oocyte 
obtained from superovulation [55]. While studies in 
humans are more difficult to interpret due to confounding 
factors, there are now several reports showing an 
increase in imprinting disorders in children from follicle 
stimulation and ovulation induction without IVF [56, 
57]. Further, a recent human study examining 4 year 
outcomes of patients that had IVF treatment either with 
or without hormonal stimulation determined that an 
increase in blood pressure in the children was coincident 
with administration of ovarian stimulation [58]. In 
addition human oocytes retrieved after controlled ovarian 
hyperstimulation present a different methylation pattern 
to those ovulated naturally and have hypomethylation in 
the imprinted region KCNQ1OT1 gene indicating ovarian 
hyperstimulation can alter oocyte epigenetic marks [59, 
60].
4.2  Embryo Culture Media
Embryo culture media design has moved from a simple 
balanced salt solution to the complex commercial 
media systems used today (both single phase and 
sequential) which contain an array of nutrients including 
carbohydrates and amino acids with the composition 
based on the contents of the reproductive tract milieu [61]. 
During the development of these culture media, studies 
found that embryo development and blastocyst quality 
and viability were heavily influenced by their composition. 
The presence of metal ions, serum, ammonium as well as 
media lacking key ingredients such as amino acids were 
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shown to delay embryo development as well as alter 
perinatal outcomes including birth weight [62-65]. Further, 
rodent models have demonstrated that both imprinting 
and epigenetic marks such as changes to methylation 
marks in embryos can be influenced by the composition of 
the culture media, with sub-optimal media or conditions 
(such as supplementation with BSA, use of high oxygen) 
resulting in altered expression of imprinted genes [66, 67]. 
The first evidence that culture media may influence 
development of the offspring in the human was reported in 
2010 in a study that compared two well known sequential 
culture media systems [68]. This study demonstrated a shift 
in the birth weight curve, with babies born from embryos 
cultured in media from one manufacturer being in average 
200g heavier than those born from embryos cultured in 
a different manufacturer’s media [68]. These results were 
subsequently confirmed in a larger cohort with similar 
trends seen in children born after frozen embryo transfer 
[69]. In addition culture media also influenced the number 
of children born with low birth weight (<2500g) and low 
birth weight for gestational age [69]. There are studies that 
have failed to replicate these findings however it should 
be noted that all of these studies have small numbers of 
patients involved and there are often differences in other 
aspects of the culture systems (such as culture media type 
and gas phase used) and patient drug regimes that may 
also be contributing to these outcomes [70, 71]. 
In addition to altering birth weight, embryo culture 
media has also been shown to significantly alter placental 
weight [72] and that the changes to offspring development 
are evident as early as the second trimester measured by 
changes to head circumference, trans-cerebellar diameter 
as well as free β-hCG [73]. Even at this early time point and 
after adjusting for confounding factors it was determined 
that fetal size was consistent with a gestational age of 
approximately 3 days longer. Although the impacts of this 
altered growth is currently unknown it has previously 
been demonstrated that low free β-hCG levels (which is 
produced by the syncytiotrophblast cells) is associated 
with fetal growth restriction and small for gestational age 
(SGA) [74, 75]. It was postulated that these changes in birth 
weights of the infants may be due to epigenetic alterations 
in the embryo which may in turn alter developmental 
programming of fetal and placental tissues. To this end 
a recent study demonstrating that gene expression levels 
and methylation levels are altered in both fetuses and 
placenta of children born from assisted reproductive 
techniques [76]. However, large cohort studies are required 
to further examine this phenomenon.
4.3  Intracytoplasmic Sperm Injection (ICSI)
ICSI was first reported in the 1990’s primarily to treat 
male factor infertility with the first live birth in 1992 
[77]. Although now a routine part of IVF treatment, 
studies have demonstrated that children born from 
ICSI have an increased risk for congenital birth defects 
compared to those conceived from natural conception 
[78, 79]. Studies have primarily focused on perinatal 
outcomes and the incidence of congenital abnormalities 
and neurodevelopmental factors have found that 
along with decreased birth weight, ICSI is associated 
with a significant increased risk of major birth defects 
(8.6%, primarily musculoskeletal and chromosomal 
abnormalities) in children compared to those conceived 
via natural conception (4.2%) [80]. In this study however 
standard insemination IVF was also associated with 
a similar increase in congenital malformations (9.0%) 
therefore demonstrating that ICSI alone may not be 
responsible for the increased risk of birth defects. A 
subsequent study in older children (aged 5 years) showed 
that children conceived from ICSI had an increased odds 
ratio of having a major congenital malformation (2.77 
CI 1.41-5.46) which was higher than children created 
by standard insemination IVF (1.80 CI 0.85-3.81). The 
difference between the two insemination methods was 
primarily due to an increase in malformations in the male 
offspring urogenital system [80] which has also been 
demonstrated in other studies [79, 81]. Children born from 
ICSI were also more likely to have significant childhood 
illness, surgical operations and admissions to hospital 
[82]. More recently in a large study of over 300,000 births 
it was concluded that children born from ICSI have a 
significantly higher odds ratio for birth defects (1.77 (CI: 
1.47-2.12: 9.9%) compared to IVF of 1.26 (CI 1.07-1.48: 7.2%) 
[47]. It therefore has been concluded from these studies 
that there was a pressing need to do further monitoring 
of children born from IVF technology to assess changes in 
susceptibility to other associated issues such as increased 
risk of cancer and decreased fertility (especially in light 
of the urogenital abnormalities in the male ICSI children) 
[80, 83]. In addition to congenital abnormalities it has also 
been documented that the mental developmental capacity 
of boys born from ICSI was significantly lower at 1 year than 
compared to children born from IVF, and ICSI children 
also showed delayed development in memory, problem 
solving and language skills [84]. It is possible that these 
differences may be due to variation in the patient cohort 
(ICSI is primarily used for male factor infertility where 
as standard insemination is used primarily for maternal 
infertility) or the technology itself (ICSI requires the 
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invasive injection of a sperm into the oocyte which occurs 
along with culture media and PVP (polyvinylpyrrolidone) 
which is used for sperm immobilisation and isolation) and 
this requires further investigation. Again whether these 
effects of ICSI are a result of genetic or epigenetic factors 
are unclear. Although a recent study did demonstrate that 
the dsyregulation in methylation in placentas from ICSI 
conceived children were more altered compared to IVF 
children [76], another study determined no increased risk 
of DNA methylation changes at 6 differentially methylated 
regions (DMRs) in children conceived by either IVF or ICSI 
[85]. However, a key limitation to date is the small size 
of studies which may be underpowered to detect minor 
differences. 
4.4  Frozen Embryo Transfer
The outcomes of offspring born after fresh or frozen 
(FET) embryo transfer has been the focus of a number of 
studies and there is now a significant body of evidence 
that demonstrates that elective frozen embryo transfer 
(eFET) may lead to improved ART outcomes. The first 
study to report on this was in 2010, demonstrating that 
children born from fresh transfer had an increased risk 
of blastogenesis associated birth defects compared to 
FET pregnancies [86]. It was proposed that this difference 
may likely due to either the transfer of a fresh embryo into 
an abnormal endometrial hormonal milieu induced by 
ovarian stimulation or from the cryopreservation process 
acting as a ‘selection gate’ thus ensuring that only the 
most viable embryos survived for transfer. To follow on a 
meta-analysis also concluded that children born from FET 
had a significantly decreased risk of perinatal mortality, 
pre-term birth, low birth weight and SGA than those born 
from fresh embryo transfer [87]. Although there is some 
concern that FET may actually be associated with large for 
gestational age and fetal macrosomia [88], the evidence 
of increases in fetal weight with FET compared to fresh 
transfer means that the possibility of eFET is gaining 
traction. However, large randomised controlled trials 
(RCT’s) are required before the field changes practice and 
further studies on offspring health from either technology 
are required also to determine why the children born from 
different ART technology have different phenotypes and 
how epigenetic programming may be involved [89]. 
4.5  ART, epigenetics and imprinting 
disorders
Recent studies have suggested a link between ART and 
epigenetic modifications providing a possible mechanism 
for this non-genetic inheritance of altered phenotype [90]. 
Pre-implantation embryo culture has been demonstrated 
to alter methylation and imprinted gene expression in 
animal models when compared to in vivo derived embryos 
[91-93]. In addition, large offspring syndrome (LOS) in 
ruminants, which is seen after in vitro maturation and 
in the presence of serum in the culture media, and has 
been linked to altered methylation patterns and reduced 
expression of imprinted genes [91]. In the human, several 
case studies have suggested an association between ART 
and imprinting disorders, with an increase in Beckwith-
Wiederman and Angelman syndrome as well as changes 
to imprinted loci in these children although more recent 
studies have failed to show any association [49, 94-99]. Due 
to the fact that the relative risk for imprinting disorders 
appears to be the same between sub-fertile couples with 
or without ART the increase in these imprinting disorders 
may in fact be attributed the subfertility rather than the 
ART however this remains to be confirmed [50]. 
5  Non-genetic inheritance and 
alternative art technologies 
The increasing push to improve patient care and clinical 
pregnancy rates via advancements and new treatment options 
in the ART industry means that clinicians are now able to 
access a number of new technologies that may have not 
undergone a standard pathway of preclinical through clinical 
trials. Previous examples of this include the introduction of 
ICSI in the early 1990s for the treatment of male infertility and 
more recently embryo biopsy for providing pre-implantation 
genetic testing, both which were adopted quickly into main 
stream clinical practice. In addition new technologies are now 
being investigated that are focused on not only maintaining 
the inherent viability of the embryo but trying to improve 
its quality and thus increasing the chance of pregnancy. 
Therefore it is of vital importance that these technologies are 
vetted for safety before they are implemented as the impact on 
offspring phenotype and long term disease susceptibility is 
currently unknown.
5.1  Ooplasmic transfer 
The first live birth as a result of ooplasmic transfer 
occurred back in 1997 and was first adapted for women 
who had recurrent implantation failure [100]. Ooplasmic 
transfer is the process whereby the cytoplasm of a healthy 
donor oocyte is injected and replaces the cytoplasm of 
the recipient oocyte, and has been offered to infertile 
patients in the past who are proposed to have perturbed 
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cytoplasmic factors such as mtDNA, mRNA, abnormal 
mitochondria function or an inheritable mitochondrial 
disorder [101] with live births being reported [102-104]. 
One of the main concerns with ooplasmic transfer is the 
generation of heteroplasmic oocytes where both donor and 
recipient mitochondrial haplotypes are present. Although 
no apparent abnormalities have been detected in live 
heteroplasmic children [105] it is now known in animal 
models that phenotypic and epigenetic modifications are 
apparent [106-109]. In mammals the oocyte cytoplasm 
supplies the necessary mRNA and protein requirements 
for the initial epigenetic reprogramming events that occur 
in the male and female pronucleus before activation of the 
maternal and paternal genomes [110, 111]. Therefore it’s 
plausible that undesired epigenetic modifications could 
arise from the donor ooplasm of one genotype on the 
maternal and paternal pronucleus of different genotypes 
therefore altering early epigenetic reprogramming at 
fertilisation and impacting on offspring health [109]. The 
long term safety of cytoplasmic transfer has not been 
validated and more research should be performed before 
it is routinely offered to patients. 
5.2  Growth factors in embryo culture media 
A number of different growth factors (GF) all proposed 
to improve blastocyst development rates and clinical 
pregnancy outcomes have been supplemented in human 
embryo culture media with the intent to improve embryo 
development and increase the chance of achieving a 
viable pregnancy. These include epidermal growth factor 
[112], insulin-like growth factor [113], heparin-binding 
epidermal growth factor [114], leukemia inhibitory factor 
[115], platelet-derived growth factor [116], brain-derived 
neurotrophic factor [117], platelet activation factor [118] 
and more recently granulocyte-macrophage colony-
stimulating factor (GM-CSF) [119]. The addition of GF 
to media is proposed to be beneficial to embryo growth 
promoting faster growth, and also act on embryo receptors 
to reduce apoptosis [120-122]. However, the use of GF in 
human embryo culture media is not well regulated and in 
animal models a number of these GFs have been associated 
with large offspring syndrome in sheep [91] a number of 
these GF‘s (present due to either serum or co-culture with 
granulosa cells) have been associated. With improvements 
to offspring phenotypes only seen when embryos were 
grown in suboptimal culture conditions [123, 124], which 
was somewhat mirrored by a recent RCT on GM-CSF which 
showed a benefit only when the albumin concentration 
was reduced to a level that reduced pregnancy rates in 
the control group [119]. In other cell types GFs have been 
shown to alter activity of methyltransferases (DNMTs) 
causing hypermethylation of CpG islands in cancer 
cells [125]. These same pathways are important in early 
embryogenesis which therefore raises the possibility that 
similar epigenetic pathways could be regulated by growth 
factors added to embryo culture media. Until further 
research determines long term impacts of GFs in embryo 
culture media on children’s health, GFs in clinical practice 
should be viewed with caution. 
5.3  Methyl donors
A more recent phenomenon is the addition of either methyl 
donors to human embryo culture media (i.e. methionine, 
vitamin B12, folic acid, choline, and vitamin B6) [126], or 
through patient ingestion through natural/alternative 
medicines at conception (i.e. high levels of folate) [127]. 
Many of these methyl donors can alter DNA methylation 
by interfering with 5-adenosylmethionine mediated 
methylation an essential precursor for establishing 
de novo methylation patterns as well as duplicating 
methylation patterns following DNA replication during 
early embryo development, while its by-product 5-adenosyl 
homocysteine can directly inhibit DNA methyltransferase 
activity [128]. As mammalian one-carbon metabolism is 
dependent on dietary methyl donors and cofactors [129], 
the nutritional components within embryo culture media 
could plausibly alter embryo epigenetics by influencing 
the establishment of DNA and histone methylation. The 
methyl donor levels in commercially available human 
embryo culture media display a remarkably wide range 
for example the concentration of methionine ranges 
from 0 to 100 µM [126]. While the addition of methyl 
donors is required for cell culture, numerous studies 
have now shown that methyl donor levels (in culture or 
via diet) can directly influence DNA methylation levels. 
For example diet supplementation of female agouti mice 
before and during pregnancy with extra folic acid, vitamin 
B12, betaine, and choline increased DNA methylation 
at Axin(Fu), thereby reducing by half the incidence of 
tail kinking in offspring [130]. While folic acid dietary 
supplementation after 12 weeks of gestation altered 
offspring repeat element and imprinted gene methylation 
in human cord blood [131]. Additionally when added to 
cell culture media methyl donors altered the methylation 
patterns of regulatory sequences of key imprinting genes 
in rodent oocytes [132]. A number of studies have linked 
human ART within increased imprinting disorders in 
humans [133-135], whether these changes are due to the 
sub fertility of the patients or ART technologies, including 
methyl donors in culture media, remain to elucidated. 
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6  Conclusion 
There is now significant evidence, at least in animal 
models, that the environment in which the developing 
gamete matures can alter the phenotype of resultant 
offspring. With the primary mechanism hypothesised to 
occur via alterations to critical non-genetic programming 
such as epigenetic modifications. In the human, in vivo 
environmental exposures of maternal and paternal 
gametes to changes in nutrition as well as toxins and 
smoking can significantly alter offspring phenotype. In 
addition concern has been raised about the children born 
from ART as they also can display altered phenotypes 
compared to children conceived naturally. Although there 
is speculation that this is due to the parents being infertile, 
there is also early emerging evidence that changes to in 
vitro environmental conditions during ART (i.e. media 
compositions, use of ICSI and oxygen concentrations) 
can alter epigenetic marks of gametes and embryos 
thus raising the possibility of non-genetic inheritance 
determining fetal phenotypes after ART. This therefore 
warrants the need for adequately powered studies to 
examine whether these observations are due to parental 
subfertility or whether ART technology can change 
offspring phenotypes through epigenetic mechanisms 
and, if so, how can the technology be improved to prevent 
this from occuring.
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